TCL Archive Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer November 28, 2014
TCL Archive PFS Is A Benefit “In The Right Context,” Pazdur Says In Q&A On Avastin Approval. February 29, 2008